 Connor Clark Lunn Investment Management Ltd. trimmed its stake in PDL BioPharma Inc NASDAQ:PDLI by 8.7 during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 4,007,336 shares of the biotechnology companys stock after selling 379,702 shares during the quarter. Connor Clark Lunn Investment Management Ltd.s holdings in PDL BioPharma were worth 13,004,000 ... 